Validation of EIQ AI at Leading Scientific Conference
Filed with ASX · · 2 pages · English
Earlier from EchoIQ
- Investor Presentation
- Echo IQ Commences New Heart Failure Clinical Study Using AI
- US FDA Application Lodged
- Quarterly Report
- Appendix 4C Cash Flow Report
Later from EchoIQ
- Strategic Integration Partnership Agreement with ScImage Inc
- Groundbreaking study results for Heart Failure AI solution
- Echo IQ Raises $7.1 million
- Major Milestone Achieved with FDA Clearance for EchoSolv AS
- US Based CEO Appointed to Execute Commercialisation Strategy
Follow EchoIQ into a list and get an email when it puts out news.
Follow EchoIQ